ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Neuropeptide PACAP Protects Hepatocyte against Liver Ischemia/Reperfusion Injury by Promoting Yes-Associated Protein (YAP) Function

Z. Xue, Y. Liu, C. Zhang, R. Busuttil, J. Kupiec-Weglinski, H. Ji.

Dept of Surgery, The DumontUCLA Transplant Center, Los Angeles, CA.

Meeting: 2018 American Transplant Congress

Abstract number: A64

Keywords: Hepatocytes, Ischemia, Mice, Oxidant stress

Session Information

Session Name: Poster Session A: Innate Immunity; Chemokines, Cytokines, Complement

Session Type: Poster Session

Date: Saturday, June 2, 2018

Session Time: 5:30pm-7:30pm

 Presentation Time: 5:30pm-7:30pm

Location: Hall 4EF

Background: Previously we have demonstrated that neuropeptide pituitary adenylate cyclase-activating polypeptides (PACAP) suppressed local inflammation, and protected liver against IRI by innervating the liver and immune cells. Recently, we focused on Yes-associated protein (YAP), a regulator of cellular anti-oxidation and regeneration, which drives cell proliferation and promotes survival. The current work studied how PACAP prevented hepatocellular damage and promoted hepatocyte homeostasis/regeneration by promoting YAP function. Methods&Results: Exogenous PACAP therapy protected liver against IR stress mediated damage, while PACAP KO mice showed increased susceptibility to hepatic IRI. Interestingly, unlike in WT mates, IR stress failed to mediate YAP gene induction in PACAP deficient livers, whereas PACAP monotherapy promoted YAP significantly in WT IR-stressed livers. To test whether PACAP induced YAP is essential for ameliorating liver damage during IR, we employed verteporfin (VP), an inhibitor that blocked YAP function. VP treatment alone could exacerbate the IR-induced liver injury in WT mice, as evidenced by elevated serum alanine aminotransferase (sALT) level and damaged hepatic architecture. In addition, VP restored liver IR damage in PACAP-pretreated mice, as evidenced by increased sALT level, accumulated hepatic ROS, and deteriorated liver pathology (more severe lobular edema, widespread hemorrhage, and congestion/hepatocellular necrosis), compared with PACAP monotherapy group (p<0.001). In parallel, PACAP treatment diminished otherwise abundant hepatocellular necrosis/apoptosis after IR insult, as evidenced by decreased frequency of TUNEL+ cells and caspase-3 activity. However, VP supplement significantly aggravated liver damage by elevated frequency of TUNEL+ cells and increased caspase-3 activity. Consistently, PACAP-induced YAP ameliorated hydrogen peroxide (H2O2)-triggered necrosis in primary hepatocyte cultures in vitro. Conclusion: Our novel findings document the neural immunomodulation of PACAP-mediated YAP signaling in hepatic homeostasis and cytoprotection in liver IRI. Because the enhancement of neural modulation differentially regulates local innate inflammation and hepatocyte survival, these results provide the rationale for novel neuropeptide-based approaches to manage liver IRI in transplant patients.

CITATION INFORMATION: Xue Z., Liu Y., Zhang C., Busuttil R., Kupiec-Weglinski J., Ji H. Neuropeptide PACAP Protects Hepatocyte against Liver Ischemia/Reperfusion Injury by Promoting Yes-Associated Protein (YAP) Function Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Xue Z, Liu Y, Zhang C, Busuttil R, Kupiec-Weglinski J, Ji H. Neuropeptide PACAP Protects Hepatocyte against Liver Ischemia/Reperfusion Injury by Promoting Yes-Associated Protein (YAP) Function [abstract]. https://atcmeetingabstracts.com/abstract/neuropeptide-pacap-protects-hepatocyte-against-liver-ischemia-reperfusion-injury-by-promoting-yes-associated-protein-yap-function/. Accessed June 1, 2025.

« Back to 2018 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences